申请人:Tango Therapeutics, Inc.
公开号:US20220127256A1
公开(公告)日:2022-04-28
Compounds are provided according to Formula (I):
and pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof; wherein R
1
, R
2
, R
3
, R
4
, R
6
, R
7
, R
8
and n are as defined herein. Compounds of the present invention are contemplated useful for the prevention and treatment of a variety of conditions.